These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22673947)

  • 1. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
    Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
    Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
    Vagace JM; Caceres-Marzal C; Jimenez M; Casado MS; de Murillo SG; Gervasini G
    Am J Hematol; 2011 Jan; 86(1):98-101. PubMed ID: 21064136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
    Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
    Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
    Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
    Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
    Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
    J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
    Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
    Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children.
    Dufourg MN; Landman-Parker J; Auclerc MF; Schmitt C; Perel Y; Michel G; Levy P; Couillault G; Gandemer V; Tabone MD; Demeocq F; Vannier JP; Leblanc T; Leverger G; Baruchel A
    Leukemia; 2007 Feb; 21(2):238-47. PubMed ID: 17170721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of methotrexate-induced stroke-like neurotoxicity.
    Watanabe K; Arakawa Y; Oguma E; Uehara T; Yanagi M; Oyama C; Ikeda Y; Sasaki K; Isobe K; Mori M; Hanada R; Koh K
    Int J Hematol; 2018 Dec; 108(6):630-636. PubMed ID: 30182170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
    Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
    J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan Administration on Day 0 and Day 7 for Secondary Prevention of Methotrexate-induced Neurotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Case Series.
    Fustino NJ; Juhl K; Leister J
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e284-e287. PubMed ID: 31929386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.
    Inaba H; Khan RB; Laningham FH; Crews KR; Pui CH; Daw NC
    Ann Oncol; 2008 Jan; 19(1):178-84. PubMed ID: 17947226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia.
    Aytaç S; Yetgin S; Tavil B
    Turk J Pediatr; 2006; 48(1):1-7. PubMed ID: 16562778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A woman who couldn't speak: report of methotrexate neurotoxicity.
    Szawarski P; Chapman CS
    Postgrad Med J; 2005 Mar; 81(953):194-5. PubMed ID: 15749798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
    Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.
    Rupakumar T; Sankar A; Vijayasekharan K; Varikkattu Rajendran P; Chellapan Sojamani G; Rajeswari B; Nair M; Anandarajan R; Dennis D; Thankamony P
    Br J Haematol; 2024 Jul; 205(1):220-228. PubMed ID: 38797523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurotoxicity during induction treatment of childhood acute lymphoblastic leukaemia--two case reports].
    Kostić G; Jovancić D; Saranac L; Bjelaković B
    Srp Arh Celok Lek; 2009; 137(5-6):266-70. PubMed ID: 19594068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate.
    Eichler AF; Batchelor TT; Henson JW
    Neuro Oncol; 2007 Jul; 9(3):373-7. PubMed ID: 17522329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
    Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
    Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.